 ROCKVILLE, MD, Oct. 28, 2020 GLOBE NEWSWIRE -- MacroGenics, Inc. NASDAQ: MGNX, a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the third quarter of 2020 after the market closes on Wednesday, November 4, 2020. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Wednesday, November 4, 2020 at 4:30 p.m. ET. The conference call can be accessed by dialing 877 303-6253 domestic or 973 409-9610 international five minutes prior to the start of the call and providing the Conference ID 5986584. 